Results 11 to 20 of about 22,001 (226)

Lupus anticoagulant in patients with COVID-19: A review [PDF]

open access: yesJournal of Preventive Epidemiology, 2021
Introduction: Coronavirus disease 2019 (COVID-19) is characterized by a pro-coagulant state that can lead to fatal thromboembolic events. A high prevalence of lupus anticoagulant has been shown in several studies that may at least partially explain the ...
Milad Nazari Sabet   +2 more
doaj   +1 more source

Determinación del anticoagulante lúpico: Experiencia de 4 años Determination of the lupus anticoagulant: A 4-year experience

open access: greenRevista Cubana de Hematología, Inmunología y Hemoterapia, 2005
Se realizó un estudio retrospectivo de los resultados de la determinación del anticoagulante lúpico (AL) realizadas en el período comprendido entre julio del 2000 y julio del 2004 en el laboratorio de hemostasis del Instituto de Hematología e Inmunología.
Alina Díaz Concepción   +2 more
doaj   +1 more source

Massive thrombosis and phlegmasia cerulea dolens while taking rivaroxaban: case report and review [PDF]

open access: yesJornal Vascular Brasileiro, 2021
Our study describes a fatal case of phlegmasia cerulea dolens and massive venous thrombosis in a patient taking rivaroxaban regularly to treat cerebral venous sinus thrombosis. Blood tests samples were positive for lupus anticoagulant.
Diego Chemello   +6 more
doaj   +1 more source

Lupus anticoagulant. [PDF]

open access: yesStroke, 1987
Summary Circulating lupus anticoagulant occurs in 5–37% of all patients with systemic lupus erythematosus. Its occurrence is not restricted to collagen vascular disease states. Lupus anticoagulant causes a prolongation of certain laboratory coagulation studies yet it is associated in vivo with a history of systemic intravascular ...
N A, Aunsholt, J, Stentoft
  +8 more sources

How to Achieve Standardization? Diluted Russell Viper Venom Test for Lupus Anticoagulant Detection in a Chinese Female Population

open access: yesClinical and Applied Thrombosis/Hemostasis, 2021
On an international scale, guidelines and proposals for lupus anticoagulant detection have been published over the last 20 years, but until now, standardization has not been completely realized. The aim of this study was to evaluate the different ways of
Feng Lu   +4 more
doaj   +1 more source

Prothrombin Is Responsible for the Lupus Cofactor Phenomenon in a Patient with Lupus Anticoagulant/Hypoprothrombinemia Syndrome

open access: yesTH Open, 2020
Lupus anticoagulant is a misnomer as it is commonly associated with thromboembolic events. In few cases, the name retains its literal meaning when it characterizes patients with a bleeding disorder.
Vittorio Pengo   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy